Immunohistochemical Expression of Survivin and Its Relationship with Cell Apoptosis and Proliferation in Ameloblastomas

Table 1

Average expression percentages of apoptosis regulatory proteins according to the ameloblastic histological types and subtypes.

Histological type	Number of cases	Mean ± SD
		%Cytoplasmic Survivin	%Bcl-2	%Bax
Solid/multicystic	38	45 ± 31.6		40.2 ± 25.8
FSA	6	43.3 ± 34.4	58.3 ± 29.2	46.6 ± 30.1
ASA	10	43 ± 27.5	58 ± 30.4	46 ± 22.7
PSA	22	46.3 ± 33.8	37.2 ± 28.3	35.9 ± 26.3
Unicystic	72	39.5 ± 29.7		43.1 ± 25.4
LUA	8	27.5 ± 30.1	33.7 ± 19.2	37.5 ± 31.1
MUA	24	44.6 ± 34.6	43.3 ± 26.6	48.3 ± 24.1
IUA	40	39 ± 29.6	36.7 ± 28.3

FSA: follicular solid/multicystic ameloblastoma, ASA: acanthomatous solid/multicystic ameloblastoma, PSA: plexiform solid/multicystic ameloblastoma, LUA: luminal unicystic ameloblastoma, MUA: Mural unicystic ameloblastoma, IUA: intraluminal unicystic ameloblastoma. Kruskal-Wallis test; the values in bold indicate statistical significance. (). Solid/multicystic ameloblastoma: ^a%cytoplasmic Survivin, vs. %Bcl-2, , Unicystic ameloblastoma: ^bBax, vs. Bcl-2, , Intraluminal ameloblastoma: ^c%cytoplasmic Survivin vs. %Bax, .